About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,055 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,055 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5241-5260 of 42,055 trials

WithdrawnAllogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis SuppurativaThis study is an open-label, dose-escalation study enrolling 15 participants. There are 3 cohorts: 1.NCT04541550·Houston, Texas CompletedTipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast CancerThis phase I/II trial is studying the side effects and best dose of tipifarnib when given together with gemcitabine hydrochloride and to see how well they work in treating women…NCT00100750·Houston, Texas Not yet recruitingA Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice ProsthesesThe goal of this clinical research study is to learn if regular use of Provox® ActiValve® by patients after a total laryngectomy with TEP can decrease the number of VP device…NCT07369050·Houston, Texas RecruitingClinical and Molecular Features of Oral Premalignancy and Oral CancerInvestigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response.NCT06550050·Houston, Texas

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedRituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)Rituximab is a man-made antibody used to treat certain types of cancer.NCT00106184·Birmingham, Alabama and 30 others

CompletedPlatform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel CombinationsThis study is designed to evaluate multiple clinical hypotheses and mechanistically-defined combinations to evaluate the safety and efficacy of immunotherapy combinations in…NCT03835533·Los Angeles, California and 5 others

CompletedStudy of ALXN1850 in Participants With Hypophosphatasia (HPP)This is an open-label, dose-escalating study to assess safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and immunogenicity of ALXN1850 when given intravenous (IV)…NCT04980248·Las Vegas, Nevada and 3 others

CompletedTapinarof for the Treatment of Plaque Psoriasis in Adults (3001)This is a randomized, double-blind, vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque…NCT03956355·Birmingham, Alabama and 52 others

RecruitingSafety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line TreatmentThis is a Phase II, multisite, open-label study consisting of two parts in participants with advanced/metastatic Non-small Cell Lung Cancer (NSCLC) which progressed after a…NCT06841055·Birmingham, Alabama and 29 others

RecruitingPhase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary CarcinomaTo learn if sacituzumab tirumotecan can help to control advanced or metastatic SMARCB1-deficient RMC in patients whose disease has progressed after receiving at least 1 treatment.NCT07438626·Houston, Texas

WithdrawnAugmented Macular Pigment-containing Nutraceutical and Central Visual FunctionThe purpose of this study is to prospectively analyze changes in macular pigment optical density and dermal carotenoid levels as they relate to visual field function in patients…NCT04676126·San Antonio, Texas

CompletedDalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeRATIONALE: Dalteparin may stop the growth of cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth.NCT00028678·Tampa, Florida and 11 others

CompletedPrevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial…NCT00040378·Birmingham, Alabama and 90 others

CompletedSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for LeukemiaEx vivo expanded human myeloid progenitor cells (hMPCs; CLT-008) have the potential to accelerate neutrophil recovery and decrease the risk of febrile neutropenia and infection in…NCT01297543·La Jolla, California and 9 others

CompletedIMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft RecipientsThis study will determine the relative efficacy and safety of up to 100 days Valcyte prophylaxis relative to up to 200 days Valcyte prophylaxis when given for the prevention of…NCT00294515·Birmingham, Alabama and 79 others

CompletedPrevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaRandomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or…NCT01256476·Huntsville, Alabama and 43 others

RecruitingAcute and Chronic Effects of Oral Ketones in Subjects With HFrEF and DiabetesThis study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure…NCT06108076·San Antonio, Texas

CompletedRitonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.The purpose of this study is to evaluate the non-inferiority of ritonavir-boosted GS-9137 relative to a ritonavir-boosted Comparator Protease Inhibitor when used as part of…NCT00298350·Phoenix, Arizona and 53 others

Not yet recruitingZanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEAThe purpose of this study is to collect real-world data to describe the effectiveness and tolerability of first line (1L) zanidatamab-containing therapies and describe the…NCT07780968·Orange, California and 1 other

CompletedA 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus…NCT00784550·Riverside, California and 34 others

PreviousPage 263 of 2103Next

Heart Diseasein Texas